Biomarker Signature of Stroke Aetiology Study: The BIOSIGNAL-Study

Active, not recruiting

Phase Results N/A

Summary of Purpose

The three-year cumulative risk of a recurrent stroke, dependent on aetiology, is up to 25 per cent. At present, preventing recurrence relies on a broad approach to reduce risk factors associated with atherosclerosis, heart disease and metabolic disorders. However, more specific interventions, such as anticoagulation and surgery or stenting, need aetiologic information. BIOSIGNAL aims to determine where the most...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 2 May 2018.

1 Sep 2014 17 Oct 2014 1 Oct 2018 1 Oct 2018 1 May 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Probability Sample

Contacts